Rank #1454PHAR

Pharming Group N.V.

$16.47

-1.85% (Daily)

Market Cap

$1.15B

Revenue

$362.27M

Rank by MCap

#1454

Sector

Healthcare

Industry

Biotechnology

CEO

Mr. Fabrice Chouraqui Ph.D., Pharm.D.

Headquarters

Leiden

Employees

404

About Pharming Group N.V.

Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company's lead product is RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K? inhibitor for the treatment of activated ...